High Vista Strategies LLC Vera Therapeutics, Inc. Transaction History
High Vista Strategies LLC
- $255 Million
- Q3 2024
A detailed history of High Vista Strategies LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 22,010 shares of VERA stock, worth $824,054. This represents 0.38% of its overall portfolio holdings.
Number of Shares
22,010
Previous 9,162
140.23%
Holding current value
$824,054
Previous $331,000
193.66%
% of portfolio
0.38%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
183Shares Held
55.6MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$161 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$147 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$125 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$111 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$105 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.01B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...